Published in Acta Gastroenterol Belg on January 01, 1971
A proposal for the classification of sigma binding sites. Trends Pharmacol Sci (1992) 2.65
Effect of somatostatin on diarrhea and on small intestinal water and electrolyte transport in a patient with pancreatic cholera. Dig Dis Sci (1982) 2.14
[The automatic determination of proteolytic activity of gastric juice]. Biol Gastroenterol (Paris) (1968) 1.60
[How to express results of 24-hour gastric pH measurement? Choice of a mode of expression in 27 healthy subjects]. Gastroenterol Clin Biol (1989) 1.51
Results of surgical management in 92 consecutive patients with Zollinger-Ellison syndrome. Ann Surg (1981) 1.27
N-methyl-D-aspartate-induced neuronal activation is selectively modulated by sigma receptors. Eur J Pharmacol (1990) 1.17
Cimetidine treatment of acute and chronic Zollinger-Ellison syndrome. World J Surg (1979) 1.11
Current approach to the management of tumoral process in patients with gastrinoma. World J Surg (1986) 1.09
Diagnosis and treatment of Zollinger-Ellison syndrome. Baillieres Clin Gastroenterol (1988) 1.07
GnRH antagonists: a new generation of long acting analogues incorporating p-ureido-phenylalanines at positions 5 and 6. J Med Chem (2001) 1.06
Conditioned emotional response in rats enhances colonic motility through the central release of corticotropin-releasing factor. Gastroenterology (1991) 1.03
Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome. Gut (1992) 1.03
Evaluation of antisecretory drug therapy of Zollinger-Ellison syndrome (ZES) using 24-hour pH monitoring. Dig Dis Sci (1983) 1.02
The presence of lipocortin in human embryonic skin fibroblasts and its regulation by anti-inflammatory steroids. Biochim Biophys Acta (1985) 1.01
[Severity of desmoid tumors with retroperitoneal development in Gardner's syndrome. Apropos of 2 cases]. Rev Med Interne (1989) 0.98
Effect of somatostatin on normal and gastric-stimulated cell proliferation in the gastric and intestinal mucosae of the rat. Digestion (1979) 0.97
Delayed gastric emptying in anorexia nervosa is improved by completion of a renutrition program. Dig Dis Sci (1988) 0.97
Clinical, anatomical, and evolutive features of patients with the Zollinger-Ellison syndrome combined with type I multiple endocrine neoplasia. Pancreas (1993) 0.97
Gastric endocrine cell behavior in Zollinger-Ellison patients upon long-term potent antisecretory treatment. Gastroenterology (1989) 0.97
Gastric HCO3-stimulated ATPase: evidence against its microsomal localization in rat fundus mucosa. Biochim Biophys Acta (1974) 0.96
Clinical and experimental progression of a new model of human prostate cancer and therapeutic approach. Am J Pathol (2001) 0.95
Peripheral kappa-opioid receptors mediate the antinociceptive effect of fedotozine (correction of fetodozine) on the duodenal pain reflex inrat. Eur J Pharmacol (1994) 0.95
C1-transport in gastric micorsomes. An ATP-dependent influx sensitive to membrane potential and to protein kinase inhibitor. J Biol Chem (1980) 0.95
Distinct neuroprotective profiles for sigma ligands against N-methyl-D-aspartate (NMDA), and hypoxia-mediated neurotoxicity in neuronal culture toxicity studies. Brain Res (1995) 0.95
Acute spontaneously recovering ulcerating colitis (ARUC). Report of 6 cases. Am J Dig Dis (1977) 0.93
Determination of histamine, methylhistamines and histamine-o-phthaldialdehyde complexes by two high-performance liquid chromatographic procedures. Application to biological samples. J Chromatogr (1983) 0.93
In vitro stimulation of the prepubertal rat gonadotropin-releasing hormone pulse generator by leptin and neuropeptide Y through distinct mechanisms. Endocrinology (2000) 0.93
Pharmacokinetics of butixocort 21-propionate, budesonide, and beclomethasone dipropionate in the rat after intratracheal, intravenous, and oral treatments. Drug Metab Dispos (1991) 0.92
[Efficacy of ranitidine and cimetidine in the treatment of gastric or duodenal ulcer resistant to an initial treatment with cimetidine. Multicenter controlled therapeutic trial]. Gastroenterol Clin Biol (1985) 0.92
Vagally mediated inhibition of acoustic stress-induced cortisol release by orally administered kappa-opioid substances in dogs. Endocrinology (1989) 0.92
Fedotozine reverses ileus induced by surgery or peritonitis: action at peripheral kappa-opioid receptors. Gastroenterology (1993) 0.91
Parietal and chief cell populations in four cases of the Zollinger-Ellison syndrome. Gastroenterology (1972) 0.91
Development of gastric argyrophil carcinoid tumors in a case of Zollinger-Ellison syndrome with primary hyperparathyroidism during long-term antisecretory treatment. Cancer (1987) 0.91
JO 1784, a potent and selective ligand for rat and mouse brain sigma-sites. J Pharm Pharmacol (1990) 0.90
Central nervous system pharmacology of neuropeptide Y. Pharmacol Ther (1995) 0.90
Interleukin 1 induces a neurally mediated colonic secretion in rats: involvement of mast cells and prostaglandins. Gastroenterology (1994) 0.89
Purification and biochemical characterization of dog gastric lipase. Eur J Biochem (1991) 0.89
Dehydroepiandrosterone sulfate attenuates dizocilpine-induced learning impairment in mice via sigma 1-receptors. Behav Brain Res (1997) 0.89
Gastric endocrine cell evolution in patients with Zollinger-Ellison syndrome. Influence of gastrinoma growth and long-term omeprazole treatment. Dig Dis Sci (1993) 0.88
Effect of the histamine-1 antagonist astemizole alone or with omeprazole on rat gastric mucosa. Scand J Gastroenterol (1991) 0.88
Effect of fedotozine on the cardiovascular pain reflex induced by distension of the irritated colon in the anesthetized rat. Eur J Pharmacol (1994) 0.88
Analgesic and antiinflammatory effects of two novel kappa-opioid peptides. Anesthesiology (2001) 0.88
A C-fiber reflex modulated by heterotopic noxious somatic stimuli in the rat. J Neurophysiol (1994) 0.88
Inhibitory effect of prolonged administration of long-acting somatostatin on gastrin-stimulated fundic epithelial cell growth in the rat. Digestion (1982) 0.87
Carrageenan: effects in animals. Lancet (1970) 0.87
Ranitidine upon meal-induced gastric secretion: oral pharmacokinetics and plasma concentration effect relationships. Br J Clin Pharmacol (1982) 0.87
Opposite effects of kappa-opioid agonists on gastric emptying of liquids and solids in dogs. Gastroenterology (1988) 0.87
[Histological and cytological study of the tumoral and nontumoral endocrine pancreas in the Zollinger-Ellison syndrome]. Rev Int Hepatol (1966) 0.87
Response heterogeneity of 5-HT3 receptor antagonists in a rat visceral hypersensitivity model. Eur J Pharmacol (1996) 0.86
Inhibitors of free radical formation fail to attenuate direct beta-amyloid25-35 peptide-mediated neurotoxicity in rat hippocampal cultures. J Neurosci Res (1994) 0.86
Fedotozine, a kappa-opioid agonist, prevents spinal and supra-spinal Fos expression induced by a noxious visceral stimulus in the rat. Neurogastroenterol Motil (2000) 0.86
Neuropeptide Y and sigma ligand (JO 1784) suppress stress-induced colonic motor disturbances in rats through sigma and cholecystokinin receptors. J Pharmacol Exp Ther (1992) 0.86
Effects of fedotozine on gastrointestinal motility in dogs: mechanism of action and related pharmacokinetics. J Pharm Pharmacol (1990) 0.86
Reversal by kappa-agonists of peritoneal irritation-induced ileus and visceral pain in rats. Life Sci (1997) 0.85
Current approach to the management of gastrinoma and insulinoma in adults with multiple endocrine neoplasia type I. World J Surg (1993) 0.85
New somatostatin molecule for management of endocrine tumours. Gut (1985) 0.85
In vivo modulation of sigma receptor sites by calcitonin gene-related peptide in the mouse and rat hippocampal formation: radioligand binding and electrophysiological studies. Eur J Neurosci (1995) 0.85
Screening of preduodenal lipases in several mammals. Biochim Biophys Acta (1988) 0.85
Evidence for a non-opioid sigma binding site in the guinea-pig myenteric plexus. Life Sci (1988) 0.85
Fedotozine blocks hypersensitive visceral pain in conscious rats: action at peripheral kappa-opioid receptors. Eur J Pharmacol (1997) 0.85
Effects of neuropeptide Y, peptide YY and sigma ligands on ion transport in mouse jejunum. J Pharmacol Exp Ther (1993) 0.85
A quality of life study in five hundred and eighty-one duodenal ulcer patients. Maintenance versus intermittent treatment with nizatidine. Scand J Gastroenterol Suppl (1994) 0.85
Carrageenan and the human gut. Lancet (1970) 0.84
Management of Zollinger-Ellison syndrome. N Engl J Med (1980) 0.84
Effects of isozyme-selective phosphodiesterase inhibitors on eosinophil infiltration in the guinea-pig lung. Eur J Pharmacol (1994) 0.84
BI-RADS categorisation of 2,708 consecutive nonpalpable breast lesions in patients referred to a dedicated breast care unit. Eur Radiol (2011) 0.84
[An approach to automatic determination of the proteolytic activity of gastric juice under conditions of initial reaction rate]. Biol Gastroenterol (Paris) (1975) 0.84
Chromogranin A and pancreastatin-like immunoreactivity in serum of gastrinoma patients. Acta Oncol (1993) 0.84
Ranitidine and cimetidine in Zollinger-Ellison syndrome. Br J Clin Pharmacol (1980) 0.84
Evidence for an anti-amnesic effect of JO 1784 in the rat: a potent and selective ligand for the sigma receptor. Brain Res (1991) 0.84
[Letter: Inhibitor of H 2 histamine receptors and the Zollinger-Ellison syndrome]. Nouv Presse Med (1974) 0.83
Tonic regulation of mouse ileal ion transport by nitric oxide. J Pharmacol Exp Ther (1994) 0.83
Interest of a combined antisecretory treatment, cimetidine and pirenzepin, in the management of severe forms of Zollinger-Ellison syndrome. Digestion (1980) 0.83
Gynecomastia and histamine-2 antagonists. Lancet (1982) 0.83
Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype. Endocrinology (1999) 0.82
A novel receptor for calcitonin gene-related peptide (CGRP) mediates secretion in the rat colon: implications for secretory function in colitis. FASEB J (2000) 0.82
[Isolation and purification of a histamine-like gastrosecretagogue from gastric antral mucosa]. Gastroenterol Clin Biol (1982) 0.82
Histamine is able to suppress the inhibitory effect of somatostatin on exogenous gastrin: comparison between extractive antral histamine and synthetic histamine. Agents Actions (1983) 0.82
A 'quality of life questionnaire' adapted to duodenal ulcer therapeutic trials. Scand J Gastroenterol Suppl (1994) 0.82
Total pancreatic insufficiency in pigs: a model to study intestinal enzymes and plasma levels of digestive hormones after pancreatic supplementation by a whole pancreas preparation. Pancreas (1989) 0.82
CCK antagonists: pharmacology and therapeutic interest. Pharmacol Ther (1994) 0.82
Anti-inflammatory effect of LA 2851 and reference drugs on some models of inflammation. Investigation of the mechanism of action. Agents Actions (1982) 0.82
Comparative effects of antrocolic transposition and antrectomy on fundic mucosa and acid secretion of the rat. Gastroenterology (1973) 0.81
Antinociceptive effects of neuropeptide Y and related peptides in mice. Brain Res (1996) 0.81
[Effect of a gastrin agonist isolated from antral mucosa on gastric secretion (author's transl)]. J Physiol (Paris) (1980) 0.81
[Rat bioassay with urine (PSU) for diagnosis and postoperative follow-up in Zollinger-Ellison syndrome (author's transl)]. Acta Gastroenterol Belg (1973) 0.81
Neuropeptide Y and JO 1784, a selective sigma ligand, alter intestinal ion transport through a common, haloperidol-sensitive site. Eur J Pharmacol (1990) 0.81
Central neuropeptide Y and the sigma ligand, JO 1784, reverse corticotropin-releasing factor-induced inhibition of gastric acid secretion in rats. Br J Pharmacol (1992) 0.81
Long-term treatment with octreotide in patients with the Zollinger-Ellison syndrome. Eur J Clin Invest (1993) 0.81
Interaction of 3H-labelled synthetic human gastrin I with rat gastric plasma membranes. Evidence for the existence of biologically reactive gastrin receptor sites. FEBS Lett (1976) 0.81
Autoradiographic localization of sigma opioid receptors in the gastrointestinal tract of the guinea pig. Gastroenterology (1989) 0.81
[Efficacy of combined anti-secretory treatment (cimétidine and pirenzepin) in Zollinger-Ellison syndrome]. Nouv Presse Med (1977) 0.81
Anaphylactic colonic hypersecretion in cow's milk sensitized guinea-pigs depends upon release of interleukin-1, prostaglandins and mast cell degranulation. Aliment Pharmacol Ther (1994) 0.81
Neuropeptide Y and peptide YY interact with rat brain sigma and PCP binding sites. Eur J Pharmacol (1989) 0.81
A comparative evaluation of secretin bolus and secretin infusion as secretin provocation tests in the Zollinger-Ellison syndrome. Scand J Gastroenterol (1985) 0.81
Role of vagal afferents in the antinociception produced by morphine and U-50,488H in the colonic pain reflex in rats. Eur J Pharmacol (1994) 0.80
Central and peripheral opioid modulation of gastric relaxation induced by feeding in dogs. J Pharmacol Exp Ther (1989) 0.80
[Toxocariasis and functional intestinal disorders. Presentation of 4 cases]. Gastroenterol Clin Biol (1996) 0.80
DBM mice as a pharmacological model of maturity onset diabetes. Studies with metformin. Arch Int Pharmacodyn Ther (1979) 0.80
Intragastric pH profile during acute respiratory failure in patients with chronic obstructive pulmonary disease. Effect of ranitidine and enteral feeding. Chest (1986) 0.80